Effectiveness of a Therapeutic Exercise Program Combined With Respiratory Muscle Training in Patients With Subacute Stroke: a Randomized Clinical Trial
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 64
- 试验地点
- 1
- 主要终点
- Exercise capacity
研究概览
简要总结
Stroke has a significant impact on morbidity, mortality and healthcare expenditure globally. In addition to the motor and cognitive consequences, as well as on functional independence and social participation, it can produce alterations in the respiratory function. Scientific evidence supports the application of both therapeutic exercise programs and respiratory muscle training (RMT). However, studies that combine both interventions are limited, and to date no study has been published that examines the effectiveness of this combination in the subacute phase of stroke, which is the one that presents the widest range of neuroplasticity. Objectives: To analyze the effects of a combined therapeutic exercise and RMT program, compared to the therapeutic exercise and sham RMT program, on different variables related to functional, respiratory, swallowing and speech/voice capacity, in patients in the subacute phase of a stroke. Type of research: double-blind randomized controlled clinical trial. Design: The study will be carried out at the University Hospital Complex of A Coruña (CHUAC), where 64 patients with more than three and less than six months of evolution after a stroke will be recruited. Participants will be randomly assigned to two groups: the intervention group will perform a combined therapeutic exercise and RMT program, while the control group will combine the same therapeutic exercise program and sham RMT. The duration of the intervention will be eight weeks. The therapeutic exercise program will be carried out three days per week and will consist of a cardiovascular exercise part and a strength-endurance part. The RMT protocol will involve both the inspiratory and expiratory muscles, using the Orygen-Dual Valve® device. The control group will use the same valve but without resistance, generating a sham RMT. It will have a frequency of five days per week and will be carried out at the home of each patient. Additionally, half the subjects in the intervention group will continue the RMT protocol once the eight-week period has ended, with a frequency of two days per week, until the six-month follow-up. Possible differences between groups will be analyzed before and after the intervention, and at three and six months of follow-up, in relation to the following domains: functional capacity, functional independence, lung and respiratory muscle function, swallowing and speech/voice function, respiratory signs and symptoms, and quality of life.
详细描述
This protocol is designed to analyze the effects of a therapeutic exercise program combined with an RMT protocol in patients with subacute stroke, compared to another group that will perform the therapeutic exercise program combined with sham RMT in relation to different functional variables.
Sample size assessment: The sample size calculation was performed using the G*Power software and based on the 6 Minute Walk Test (6MWT), chosen as the main variable. The minimum clinically important difference (MCID) data from the study by Fulk et al. (MCID=130) and the standard deviation (SD) from the study by Baker et al. (conducted in patients with subacute stroke in the United Kingdom, SD=143) were used. For a two-sided hypothesis, with a statistical power of 90% and a significance level of 0.05, a sample size of 32 subjects per group would be required (assuming a 20% loss over the course of the study). Additionally, a pilot phase will be developed at the beginning of the study with eight other subjects who will not be part of the final sample, in order study the feasibility of the project.
Plan for missing data: At the end of each assessment session, all questionnaires will be checked to ensure they are complete and filled out correctly. If a participant does not attend a session, they will be phone called and rescheduled for that session. In cases where data are reported as missing, unavailable, or uninterpretable due to inconsistencies or out-of-range results, a plan will be implemented to manage these cases. Strategies will include imputing missing data and excluding cases.
Statistical analysis plan: Anaconda® software and the Python 3.8.8 programming language will be used. A descriptive analysis of the variables included in the study will be performed initially. For qualitative variables, absolute frequencies and percentages will be presented, and for quantitative variables, measures of central tendency (mean/median) and dispersion (range/standard deviation) will be presented, depending on whether they are normal or non-normal. The normality of the sample will be tested using the Shapiro-Wilk test. Per-protocol and intention-to-treat analyses will be performed to determine the effectiveness of the treatment both under ideal conditions of protocol adherence and in a more realistic context of losses throughout the intervention. To compare the results of the outcome measures between the study groups throughout the intervention, a repeated-measures ANOVA will be applied with a within-subject factor, time, which has four levels (pre-training, post-training, and at three and six months post-training), and a between-subject factor, the type of intervention (therapeutic exercise + RMT or therapeutic exercise + sham RMT). Another repeated-measures ANOVA will be applied with the same within-subject factor, and the presence or absence of maintenance sessions as a between-subject factor (only for the intervention group). The level of statistical significance will be set at p<0.05.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
盲法说明
All participants, regardless of their group, will perform the same therapeutic exercise program. In addition, they will not know whether their RMT device is sham or not (they have the same appearance). One researcher (physical therapist) will perform both the outcomes assessment and the therapeutic exercise intervention and will be blinded to the group assignment of the patients to the intervention group or the control group. Another researcher (speech therapist) will be responsible for delivering the RMT and sham RMT devices based on the randomization and instructing the patients in their use, as well as increasing the resistance of the valve and re-evaluating the execution of the protocol to confirm that it is being carried out correctly. Therefore, this last therapist will be the only one who will know the group assignments. Mechanisms will be applied to verify whether the masking of both the physiotherapist and the patients to the groups has been violated at any time.
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Those diagnosed with a first stroke occurring three to six months after the onset (subacute phase).
- •Those aged 18 years or older.
- •Those able to walk at least 10 meters, with or without walking aids and/or physical assistance from another person.
排除标准
- •Those with recurrent stroke.
- •Those with a history of chronic respiratory disease.
- •Those with other underlying neurological diseases with impaired functionality prior to the stroke.
- •Those with other cardiovascular or metabolic diseases in an unstable phase.
- •Those with severe cognitive deficits that impede understanding of the assessment tests and/or the intervention.
- •Those with severe facial paralysis that impedes proper performance of pulmonary function and respiratory muscle strength tests.
- •Those with a prior participation in a RMT program.
- •Those who participate in a cardiovascular and/or strength-endurance training program at the time of the study.
- •Those with any of the contraindications to performing the tests included in the study protocol: spirometry, respiratory muscle strength and endurance tests, and 6MWT.
- •Those with any of the contraindications to physical exercise.
研究组 & 干预措施
Intervention group
Intervention group will perform a therapeutic exercise program combined with RMT
干预措施: Therapeutic exercise program combined with RMT (Device)
Control group
Control group will perform the same therapeutic exercise program combined with sham RMT
干预措施: Therapeutic exercise program combined with sham RMT (Device)
结局指标
主要结局
Exercise capacity
时间窗: The 6MWT will be assessed before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.
The metric used to characterize the primary outcome measure will be the 6MWT. The 6MWT is a constant-load walking test that evaluates submaximal functional capacity. It consists of determining the distance a patient is able to walk at the maximum possible speed in six minutes, using standardized instructions. It will be carried out following the international standards of the American Thoracic Society (ATS) and the European Respiratory Society (ERS). The test will be performed in a hallway, with two markers delimiting the 30-meter distance. Every minute during the test, oxygen saturation, heart rate (HR), and dyspnea and fatigue of the lower limbs will be recorded, and blood pressure (BP) will be measured both before and after the test. In the first assessment session, two attempts will be made due to the learning effect, separated by a 30-minute rest period or as long as necessary until vital signs recover. A single attempt will be made in subsequent measurements.
次要结局
- Sociodemographic data(The personal interview will take place once, before the intervention.)
- Anthropometrics(Height, weight and BMI will be recorded in the first session (before intervention), and weight and BMI will be recorded in all assessment sessions (before and after intervention, and at the 3rd and 6th month of follow-up).)
- Upper and lower limb motor function(The MI will be assessed before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Fall risk(The TUG will be administered before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Swallowing-related quality of life(The SWAL-QoL will be administered before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Balance(The BBS will be administered before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Pulmonary function (FEV1/FVC)(The forced spirometry will be assessed before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Lower limb strength(The 5TSTS will be administered before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Functional independence(The FIM will be administered before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Functional ambulation(The FAC will be assessed before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Pulmonary function (PEF)(The forced spirometry will be assessed before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Pulmonary function (FEF25-75%)(The forced spirometry will be assessed before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Strength of the inspiratory and expiratory muscles(The maximal respiratory pressures will be assessed before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Cough capacity(The PCF will be assessed before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Severity of dysphagia(The GUSS will be administered before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Voice parameters(The PRAAT recordings will be assessed before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Vocal quality(The GRABS scale will be administered before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Aerodynamics (MPT)(The aerodynamics will be assessed before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Aerodynamics (MBT)(The aerodynamics will be assessed before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Aerodynamics (s/z ratio)(The aerodynamics will be assessed before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Severity of dysarthria(The item 10 of the NIHSS will be assessed before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Dyspnea(The mMRC will be administered before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Self-perceived effort(The Modified Borg Scale will be assessed before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
- Respiratory complications(The number and type of respiratory complications will be registered at baseline and until the 6-month follow-up period.)
- Quality of life (SIS-16)(The SIS-16 will be administered before the intervention, at the end of it (after 8 weeks) and at 3rd and 6th month of follow-up.)
研究者
Ana Lista Paz
PhD. Permanent Labor Professor of the Faculty of Physiotherapy at the University of Coruña
Universidade da Coruña